Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-17 Sale |
2025-01-17 9:17 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
5,584 | $0.5808 | $3,243 | 7,510 (Direct) |
View |
| 2025-01-13 Sale |
2025-01-15 4:16 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
19,542 | $0.58133 | $11,360 | 13,756 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 5:30 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
22,795 | $0.69703 | $15,889 | 19,015 (Direct) |
View |
| 2024-01-11 Sale |
2024-01-12 5:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
9,229 | $0.84654 | $7,813 | 7,874 (Direct) |
View |
| 2023-08-01 Sale |
2023-08-01 5:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
3,096 | $0.9056 | $2,804 | 4,718 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-17 9:17 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
4,440 | $1.858 | $8,250 | 7,264 (Direct) |
View |
| 2023-01-11 Sale |
2023-01-12 9:02 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
8,816 | $1.7238 | $15,197 | 8,121 (Direct) |
View |
| 2023-01-04 Sale |
2023-01-04 9:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
1,100 | $1.694 | $1,863 | 1,725 (Direct) |
View |
| 2022-08-01 Sale |
2022-08-01 9:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
2,983 | $1.7735 | $5,290 | 4,829 (Direct) |
View |
| 2022-07-05 Sale |
2022-07-05 9:00 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
1,973 | $1.6781 | $3,311 | 3,104 (Direct) |
View |
| 2022-01-18 Sale |
2022-01-18 9:03 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
4,368 | $3.1918 | $13,942 | 7,336 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-13 9:02 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
4,846 | $3.5539 | $17,222 | 1,749 (Direct) |
View |
| 2022-01-04 Sale |
2022-01-05 9:06 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
1,070 | $4.0642 | $4,349 | 1,755 (Direct) |
View |
| 2021-08-02 Sale |
2021-08-02 5:09 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
2,939 | $3.5848 | $10,536 | 4,873 (Direct) |
View |
| 2021-07-02 Sale |
2021-07-02 8:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
1,907 | $4.2649 | $8,133 | 3,170 (Direct) |
View |
| 2021-01-19 Sale |
2021-01-19 9:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
4,358 | $5.6695 | $24,708 | 7,346 (Direct) |
View |
| 2021-01-12 Sale |
2021-01-12 9:01 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
1,058 | $6.1522 | $6,509 | 1,767 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-05 9:02 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
1,065 | $5.3279 | $5,674 | 1,760 (Direct) |
View |
| 2020-08-03 Sale |
2020-08-04 9:02 pm |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
4,823 | $9.25 | $44,613 | 8,066 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-20 Option Award |
2025-02-20 5:33 pm |
N/A 2035-02-20 |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
2,686,728 | $0 | 2,686,728 (Direct) |
View |
| 2024-01-15 Option Award |
2024-01-17 5:02 pm |
N/A 2034-01-15 |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
3,109,848 | $0 | 3,109,848 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-17 9:06 pm |
N/A 2033-01-17 |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
1,912,248 | $0 | 1,912,248 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:14 pm |
N/A 2032-03-03 |
GENOCEA BIOSCIENCES INC. | GNCA | Lunger John Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-01-12 Option Award |
2022-01-13 9:04 pm |
N/A 2032-01-12 |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
1,721,328 | $0 | 1,721,328 (Direct) |
View |
| 2021-01-11 Option Award |
2021-01-11 9:00 pm |
N/A 2031-01-11 |
Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer |
1,329,528 | $0 | 1,329,528 (Direct) |
View |